• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Policy and Practice Strategies to Address the Clinical Practice Gaps Affecting the Implementation of Precision Oncology

Wednesday, June 05, 2024
Breakout Session
Diagnostics and Personalized Medicine
26A
Diagnostic testing to identify patients who could benefit from targeted therapies is a cornerstone of personalized medicine, but developers face several barriers as they seek to have their products adopted into clinical care. Many oncology patients who are eligible to receive high value personalized treatments do not. This session will describe strategies to address the clinical practice, policy and access challenges related to diagnostic testing and delivery of appropriate targeted therapies that have led to so many patients failing to receive appropriate precision oncology. Panelists will highlight overcoming challenges related to non-streamlined practices, access, data management and interpretation, and coverage and reimbursement.
Moderator
Daryl Pritchard, PhD
Senior Vice President
Personalized Medicine Coalition
Speakers
Jonathan Katchmore
Vice President of Commercial Diagnostic Strategy
Eli Lilly
Peter Hulick, MD
Medical Director, Center for Personalized Medicine
NorthShore / Endeavor Health
Robert Dumanois
Director, Reimbursement Strategy
Thermo Fisher Scientific
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS